Spectralis HRA+OCT and variants with High Magnification Module— 510(k) K182569

Name: FDA 510(k) clearance K182569
Creator: U.S. Food and Drug Administration
Published: 2018-10-18

Substantially Equivalent

Heidelberg Engineering GmbH

FDA 510(k) clearance K182569 for Spectralis HRA+OCT and variants with High Magnification Module, Substantially Equivalent on 2018-10-18. Applicant: Heidelberg Engineering GmbH. Device class: 2.

Clearance details

Applicant: Heidelberg Engineering GmbH
Product code: Code OBO
Device class: Class 2
Regulation: 21 CFR 886.1570
Advisory panel: Ophthalmic
Date received: 2018-09-18
Decision date: 2018-10-18
Decision: Substantially Equivalent
Clearance type: Special
Location: Heidelberg, DE

Download summary PDF View on FDA.gov ↗

Recent devices under product code OBO

view all

K261019 — ANTERION2026-09-11
K253837 — SPECTRALIS HRA+OCT and variants; SPECTRALIS with Flex Module2026-05-07
K252633 — UNITY DX (UDX)2025-12-23
K250553 — Tomey Cornea/Anterior Segment OCT (CASIA2)2025-07-18
K250868 — SPECTRALIS HRA+OCT and variants2025-05-12

More clearances from Heidelberg Engineering GmbH

view all

K240924 — Anterion2024-12-13
K241163 — SPECTRALIS with Flex Module2024-10-11
K240221 — SPECTRALIS HRA+OCT and variants2024-07-01
K223557 — SPECTRALIS HRA+OCT and variants2023-10-20
K230897 — Anterion2023-10-11

Data sourced from openFDA. This site is unofficial and independent of the FDA.